This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Almac Discovery Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Lewis Gazzard: Innovator in Ubiquitin Specific Protease Inhibition
Introduction
Lewis Gazzard is a notable inventor based in Craigavon, GB. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for specific proteases. His work is crucial for advancing therapeutic options in various diseases.
Latest Patents
Gazzard holds a patent for "Piperidine derivatives as inhibitors of ubiquitin specific protease 7." This invention focuses on identifying inhibitors of ubiquitin specific protease 7 (USP7) and outlines methods for their use. The patent represents a significant step forward in the search for effective treatments targeting this protease.
Career Highlights
Lewis Gazzard is associated with Almac Discovery Limited, where he applies his expertise in drug discovery and development. His role at the company allows him to work on innovative solutions that can impact patient care positively.
Collaborations
Gazzard collaborates with talented professionals in his field, including Tim Harrison and Fabio Broccatelli. These partnerships enhance the research and development process, fostering an environment of innovation.
Conclusion
Lewis Gazzard's contributions to the field of biochemistry, particularly through his patent on USP7 inhibitors, highlight his role as an influential inventor. His work at Almac Discovery Limited and collaborations with other experts further underscore his commitment to advancing medical science.